156 related articles for article (PubMed ID: 37813358)
1. Survival analysis over a 20-year period of a Brazilian cohort of blood donors coinfected HIV-HCV.
de Menezes Filho HR; Grandi G; Vaz Cardoso LP; Galvão da Silva JF; Machado SM; de Almeida-Neto C; Sabino EC; Mendes-Corrêa MC
Braz J Infect Dis; 2023; 27(5):102810. PubMed ID: 37813358
[TBL] [Abstract][Full Text] [Related]
2. Impact on mortality of being seropositive for hepatitis C virus antibodies among blood donors in Brazil: A twenty-year study.
Filho HRM; Bierrenbach ALS; Capuani MLD; Mendrone A; Benzaken AS; Machado SM; Saivish MV; Sabino EC; Witkin SS; Mendes-Corrêa MC
PLoS One; 2019; 14(12):e0226566. PubMed ID: 31856222
[TBL] [Abstract][Full Text] [Related]
3. Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.
Sawinski D; Goldberg DS; Blumberg E; Abt PL; Bloom RD; Forde KA
Clin Infect Dis; 2015 Oct; 61(7):1054-62. PubMed ID: 26082506
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
Bahirwani R; Barin B; Olthoff K; Stock P; Murphy B; Rajender Reddy K;
Liver Transpl; 2013 Jun; 19(6):619-26. PubMed ID: 23512786
[TBL] [Abstract][Full Text] [Related]
5. Intention-to-treat survival analysis of hepatitis C virus/human immunodeficiency virus coinfected liver transplant: Is it the waiting list?
Araiz JJ; Serrano MT; García-Gil FA; Lacruz EM; Lorente S; Sánchez JI; Suarez MA
Liver Transpl; 2016 Sep; 22(9):1186-96. PubMed ID: 27114030
[TBL] [Abstract][Full Text] [Related]
6. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.
Lo Re V; Volk J; Newcomb CW; Yang YX; Freeman CP; Hennessy S; Kostman JR; Tebas P; Leonard MB; Localio AR
Hepatology; 2012 Nov; 56(5):1688-98. PubMed ID: 22619086
[TBL] [Abstract][Full Text] [Related]
7. Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.
Smit C; van den Berg C; Geskus R; Berkhout B; Coutinho R; Prins M
J Acquir Immune Defic Syndr; 2008 Feb; 47(2):221-5. PubMed ID: 18223361
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the hepatic functional reserve, portal hypertension, and prognosis of patients with human immunodeficiency virus/hepatitis C virus coinfection through contaminated blood products in Japan.
Eguchi S; Takatsuki M; Soyama A; Hidaka M; Nakao K; Shirasaka T; Yamamoto M; Tachikawa N; Gatanaga H; Kugiyama Y; Yatsuhashi H; Ichida T; Kokudo N
Transplant Proc; 2014 Apr; 46(3):736-8. PubMed ID: 24767337
[TBL] [Abstract][Full Text] [Related]
9. Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.
Chalouni M; Pol S; Sogni P; Fontaine H; Lacombe K; Marc-Lacombe J; Esterle L; Dorival C; Bourlière M; Bani-Sadr F; de Ledinghen V; Zucman D; Larrey D; Salmon D; Carrat F; Wittkop L;
J Hepatol; 2021 Jan; 74(1):37-47. PubMed ID: 32798585
[TBL] [Abstract][Full Text] [Related]
10. Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection.
Peribañez-Gonzalez M; da Silva MH; Vilar FC; Seixas-Santos Nastri AC; Ferreira PA; Focaccia R; Mendes Correa MC
Ann Hepatol; 2013; 12(2):228-35. PubMed ID: 23396734
[TBL] [Abstract][Full Text] [Related]
11. Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection.
Garg S; Hoenig M; Edwards EM; Bliss C; Heeren T; Tumilty S; Walley AY; Koziel MJ; Skolnik PR; Horsburgh CR; Cotton D
AIDS Patient Care STDS; 2011 Mar; 25(3):135-41. PubMed ID: 21309706
[TBL] [Abstract][Full Text] [Related]
12. The Changing Epidemiology of Hepatitis C Virus Acquisition Among HIV-Infected Individuals in Brazil.
Ferrufino RQ; Bierrenbach AL; Rodrigues C; Figueiredo GM; Gleison D; Yapura S; de Matos MLM; Vasconcelos R; Sol Witkin S; Mendes-Correa MC
AIDS Res Hum Retroviruses; 2023 Jan; 39(1):44-49. PubMed ID: 36301937
[TBL] [Abstract][Full Text] [Related]
13. A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland.
McDonald SA; Hutchinson SJ; Bird SM; Mills PR; Dillon J; Bloor M; Robertson C; Donaghy M; Hayes P; Graham L; Goldberg DJ
Stat Methods Med Res; 2009 Jun; 18(3):271-83. PubMed ID: 19036907
[TBL] [Abstract][Full Text] [Related]
14. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.
Pineda JA; Romero-Gómez M; Díaz-García F; Girón-González JA; Montero JL; Torre-Cisneros J; Andrade RJ; González-Serrano M; Aguilar J; Aguilar-Guisado M; Navarro JM; Salmerón J; Caballero-Granado FJ; García-García JA; ;
Hepatology; 2005 Apr; 41(4):779-89. PubMed ID: 15800956
[TBL] [Abstract][Full Text] [Related]
15. Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.
Sanmartín R; Tor J; Sanvisens A; López JJ; Jou A; Muga R; Ojanguren I; Barluenga E; Videla S; Planas R; Clotet B; Tural C
HIV Med; 2014 Apr; 15(4):203-12. PubMed ID: 24245909
[TBL] [Abstract][Full Text] [Related]
16. Direct, indirect and total effect of HIV coinfection on the risk of non-liver-related cancer in hepatitis C virus-infected patients treated by direct-acting antivirals: a mediation analysis.
Chalouni M; Pol S; Sogni P; Fontaine H; Lacombe K; Lacombe JM; Esterle L; Dorival C; Bourlière M; Bani-Sadr F; de Ledinghen V; Zucman D; Larrey D; Salmon D; Carrat F; Wittkop L; ; Martinez V
HIV Med; 2021 Nov; 22(10):924-935. PubMed ID: 34402547
[TBL] [Abstract][Full Text] [Related]
17. Liver Damage in Patients with HCV/HIV Coinfection Is Linked to HIV-Related Oxidative Stress.
Huang X; Liang H; Fan X; Zhu L; Shen T
Oxid Med Cell Longev; 2016; 2016():8142431. PubMed ID: 26881041
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans.
Anderson JP; Tchetgen Tchetgen EJ; Lo Re V; Tate JP; Williams PL; Seage GR; Horsburgh CR; Lim JK; Goetz MB; Rimland D; Rodriguez-Barradas MC; Butt AA; Klein MB; Justice AC
Clin Infect Dis; 2014 Mar; 58(5):719-27. PubMed ID: 24285848
[TBL] [Abstract][Full Text] [Related]
19. Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era.
Sanmartin R; de Felipe E; Tor J; Sanvicens A; Barluenga E; Martinez E; Muga R; Jou A; Ojanguren I; López JJ; Clotet B; Tural C
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1235-43. PubMed ID: 22443303
[TBL] [Abstract][Full Text] [Related]
20. Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.
Mena A; Meijide H; Rodríguez-Osorio I; Castro A; Poveda E
HIV Med; 2017 Oct; 18(9):685-689. PubMed ID: 28230318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
